Issie Kirby
Stock Analyst at Redburn Atlantic
(1.51)
# 2,970
Out of 4,670 analysts
6
Total ratings
33.33%
Success rate
1.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Issie Kirby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Upgrades: Neutral | n/a | $85.99 | - | 1 | Oct 10, 2024 | |
| DXCM DexCom | Initiates: Neutral | $130 | $72.83 | +78.50% | 1 | May 30, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Buy | $60 | $30.81 | +94.74% | 1 | May 30, 2024 | |
| PODD Insulet | Initiates: Buy | $235 | $262.93 | -10.62% | 1 | May 30, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $125 | $100.80 | +24.01% | 2 | Mar 19, 2024 |
Alcon
Oct 10, 2024
Upgrades: Neutral
Price Target: n/a
Current: $85.99
Upside: -
DexCom
May 30, 2024
Initiates: Neutral
Price Target: $130
Current: $72.83
Upside: +78.50%
Tandem Diabetes Care
May 30, 2024
Initiates: Buy
Price Target: $60
Current: $30.81
Upside: +94.74%
Insulet
May 30, 2024
Initiates: Buy
Price Target: $235
Current: $262.93
Upside: -10.62%
The Cooper Companies
Mar 19, 2024
Upgrades: Buy
Price Target: $125
Current: $100.80
Upside: +24.01%